As the roles of CD1-restricted T cells in cancer immunity and therapeutic trials based on lipid antigens have been comprehensively reviewed (90, 111, 112), we focus on discussing the structures and functions of lipid metabolites as CD1 ligands in cancer immunity. The gene discussed is CD1C; the disease is cancer.